SIBN
Si-Bone Inc
NASDAQ · Health Care
$15.59
-0.13 (-0.83%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 174.94M | 142.41M | 196.61M | 202.38M | 156.63M |
| Net Income | -32,348,180 | -23,700,229 | 27.60M | 30.72M | 21.77M |
| EPS | — | — | — | — | — |
| Profit Margin | -18.5% | -17.6% | 14.0% | 15.2% | 13.9% |
| Rev Growth | +22.8% | +22.8% | -0.6% | +15.8% | +21.8% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 59.23M | 59.23M | 226.40M | 233.12M | 193.96M |
| Total Equity | 279.00M | 279.00M | 471.53M | 451.90M | 440.63M |
| D/E Ratio | 0.21 | 0.21 | 0.48 | 0.52 | 0.44 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | -32,378,554 | -25,040,399 | 40.52M | 44.11M | 33.24M |
| Free Cash Flow | — | — | 19.15M | 23.77M | 18.38M |